Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population T Ohtsuki, T Inada, T Arinami AKT1 is a serine/threonine kinase known as protein kinase B. AKT/glycogen synthase kinase 3 (GSK-3) signaling pathway might be relevant to dopaminerelated disorders. Recently, AKT1 was identified as a potential schizophrenia susceptibility gene in families of northern European origin. In this study, the authors attempted to confirm the association between AKT1 haplotypes and schizophrenia in a Japanese case-control population consisting of 1126 individuals. The authors observed no significant allelic or haplotypic association.
FEATURE REVIEW
Glutamate as a therapeutic target in psychiatric disorders D Javitt
Glutamate is the primary excitatory amino acid in the brain. However, no medications are available that specifically target glutamatergic systems. Dysfunction of NMDA-type glutamate receptors has been linked to the pathophysiology of schizophrenia. Stimulation of these receptors by glycine and/or D-serine leads to significant amelioration of persistent negative symptoms. Other promising targets include glycine and Dserine transport inhibitors, AMPA receptors and metabotropic glutamate receptors. Besides schizophrenia, these agents may be beneficial in treatment of depression, anxiety, PTSD and other neuropsychiatric disorders.
ORIGINAL RESEARCH ARTICLES
GABRA6 gene polymorphism and an attenuated stress response M Uhart, ME McCaul, LM Oswald, L Choi, GS Wand Exposure to stress activates glucocorticoid release. An improved understanding of the genetic contribution to differences in the stress response has significant implications because excess glucocorticoid secretion has long been implicated in the development of common neuropsychiatric and metabolic medical conditions. The authors identified a sequence variation in the GABAA alpha-6 receptor subunit gene, with high frequency of expression in the general population, which is associated with marked differences in hormonal and blood pressure responses to an acute psychological stressor as well as with distinct personality characteristics.
Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach CA Ogden, ME Rich, NJ Schork, MP Paulus, MA Geyer, JB Lohr, R Kuczenski, AB Niculescu
The authors carried a comprehensive analysis to identify candidate genes for bipolar (manic-depressive) and related disorders. They crossmatched the brain changes in gene expression from a pharmacogenomic mouse model with human genetic linkage and post-mortem data, which reduced uncertainty, and compiled a short list of high-probability candidate genes. The approach identified known (GSK3be-ta, RGS4), as well as novel, highly interesting candidate genes, such as DARPP-32, TAC1 (tachykinin 1, substance P), and PENK (preproenkephalin). This classification reveals a possible overlap between mood and pain regulation, as well as the involvement of circadian rhythm mechanisms.
SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression P Zill, TC Baghai, P Zwanzger, C Schüle, D Eser, R Rupprecht, HJ Mo¨ller, B Bondy, M Ackenheil
The authors performed an association study between 10 SNPs in a newly identified second tryptophan hydroxylase isoform gene (TPH2) and 300 patients suffering from major depression (MD) compared to 265 healthy controls. Single SNP, haplotype and LD analysis provided evidence for association with MD.
These findings may open up new research strategies for the analysis of the observed disturbances in the serotonergic system in patients suffering from several other psychiatric disorders.
Replication of 1q42 linkage in Finnish schizophrenia pedigrees J Ekelund, W Hennah, T Hiekkalinna, A Parker, J Meyer, J Lönnqvist, L Peltonen
The authors replicated their previous observation of schizophrenia linkage to chromosome 1q42. The region contains DISC1, which has been suggested as a candidate gene for schizophrenia by several independent lines of research. The results presented in this article were obtained in a study sample independent from previous reports. It is noteworthy that the evidence for linkage was obtained in essentially the same location. This provides strong support for the involvement of this region in the etiology of schizophrenia. has been linked to chromosomes 10q and 12p, but specific variants remain unconfirmed. A genomewide screen in 490 family members from 96 Caribbean Hispanics families supported linkage on 10q and 18q. With fine mapping, the evidence for linkage at 18q strengthened near 112 cM (D18S541 LOD ¼ 3.37; NPL 3.65, P ¼ 0.000177), while the evidence at 10q (134-138 cM) weakened (from 3.15, P ¼ 0.000486 to 2.1, p ¼ 0.0218). These results provide modest support for linkage on 10q and strong evidence for a new locus on 18q.
